Moreover, the EGFR–YTHDF2 axis emerges as a pivotal mechanism that governs the downregulation of LXRA gene expression, playing a crucial role in cholesterol dysregulation within the context of glioblastoma tumorigenesis. The gene discussed is YTHDF2; the disease is glioblastoma.